














































CD80-CD28 activation overcomes 
cAMP mediated suppression. 
Anti-infectious responses.
Transplant tolerance
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	 4 6 	
wit h	 0. 1	 milli o n	 of	 C T V	l a b ell e d	 L y 5. 2	 C 5 7 B L / 6	(I- A b )	W T 	O TII	 T	 c ell s	( p u rifi e d	
u si n g	 T ot al	 T	 c ell	i s ol ati o n	 Kit,	 St e m	 C ell	 T e c h n ol o gi e s)	i n	 2 0 0	 l	 v ol u m e	 of	 T	 c ell	
m e di u m	( 1 0 %	 F C S	 c o nt ai ni n g	 R P MI	 wit h	 P S G	( 1 x)	 +	 N a - p y r u v at e	( 1 x)	 +	 N E A A	
( 1 x)	 +	 L- Gl ut a mi n e	( 1 x)	 +	b -M E	( 5 0	 µ M) ).	 R oli p r a m	( 1 0	 µ M)	 o r	 D M S O	 c o nt r ol s	
w e r e	 a d d e d	i n	 a p p r o p ri at e	 w ell s	 a n d	 aft e r	 8 4	 h,	t h e	 o v a -s p e cifi c	 C D 4	 T	 c ell s	
r e s p o n s e s	 w e r e	 a n al y z e d	 b y	fl o w	 c yt o m et r y	f o r	 C T V	 dil uti o n	 a n d	 a n al y z e d	 u si n g	
Fl o wJ o	( T r e e St a r). 	
	
I n	 vi v o	 A P C	 a cti v ati o n:	 F o r	 all o g r aft	 m e di at e d	 a cti v ati o n:	W T 	o r	 	C o r o 1 a - /-	 mi c e	
w e r e	 s u bj e ct e d	t o	 m aj o r	 M H C- mi s m at c h e d	 B M 1 2	 all o g r aft	 s u r g e r y	 a n d	 at	 d a y	 8,	
t h e	 d r ai ni n g	l y m p h	 n o d e s	 w e r e	 a n al y z e d.	F o r	i nf e cti o n	 m e di at e d	 a cti v ati o n:	 W T 	
a n d	 	C o r o 1 a - /-	 mi c e	 w e r e	i nj e ct e d	 s. c	 wit h	 2 0 0	 µl	 of	 h e at	 kill e d	S al m o n ell a 	l y s at e	
( O D	 2,	i n	 P B S,	 8 5 o 	C	f o r	 1	 h)	i n	t o	t h e	 d o r s al	 s ki n	 a n d	 aft e r	 4	 d a y s,	t h e	 d r ai ni n g	
l y m p h	 n o d e s	 w e r e	 a n al y z e d	f o r	 A P C	 a cti v ati o n	 st at u s	 a s	 d e s c ri b e d	 a b o v e	i n	t h e	
“l y m p h oi d	 o r g a n	 a n al ysis”.	
	
M C M V	I nf e cti o n	 a n d	 a n al ysis :	 T r a n s g e ni c	 M C M V-Δ M 1 5 7	( a	 ki n d	 gift	f r o m	 A.	
O x e ni u s	 ( B u bi c	 et	 al.,	 2 0 0 4;	 W alt o n	 et	 al.,	 2 0 0 8) )	 w a s	 p r o p a g at e d	 o n	 m o u s e	
e m b r y o ni c	fi b r o bl a st s	( M E F).	 M C M V	tit e r	 w a s	 d et e r mi n e d	 b y	 a	 pl a q u e	 a s s a y.	
M et h yl c ell ul o s e	 w a s	 r e pl a c e d	 b y	 3 %	 A vi c el	 R C- 5 8 1.	 Mi c e	 w e r e	i nf e ct e d	 eit h e r	
i nt r a v e n o u s	(i. v.)	i nt o	t h e	t ail	 v ei n.	 Mi c e	 w e r e	i nf e ct e d	 wit h	 2	 x	 1 06 	P F U	 of	
M C M V- Δ M 1 5 7	i. v.,	 L u n g s,	li v e r,	 s pl e e n	 a n d	 s ali v a r y	 gl a n d s	 w e r e	 h a r v e st e d	 at	t h e	
i n di c at e d	ti m e	 p oi nt s	( d a y	 8,	 2 6,	 6 4	 a n d	 2 8 8)	 a n d	 vi r al	tit e r s	 w e r e	 d et e r mi n e d.	
M C M V - s p e cifi c	 C D 8	 T	 c ell s	i n	t h e	 bl o o d	 w e r e	 a n al y z e d	 b y	fl o w	 c yt o m et r y	 u si n g	
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Signaling by GPCR 
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Table S1: Related to Figure 2. Analysis of aged mice, microbiological status: Virus and parasites
Serological analysis 
WT (Positive/total) Cor1 -/-(Positive/total) !"#$%&
Viruses Ectromelia virus 0/6 0/6 !"#
Lymphocytic choriomeningitis virus (LCMV) 0/6 0/6 !"#
Mouse adneovirus, FL 0/6 0/6 $%!&#
Mouse adenovirus, K87 0/6 0/6 $%!&#
Mouse cytomegalovirus (MCMV) 0/6 0/6 $%!&#
Mouse rota virus (EDIM) 0/6 0/6 !"#
Mouse hepatitis virus (MHV) 0/6 0/6 !"#
Murine Norovirus (MNV) 4/6 0/6 '()**+*!"#
Mouse parvo virus (MPV) 0/6 0/6 !"#
Minute virus of mice (MVM) 0/6 0/6 !"#
Pneumonia virus of mice (PVM) 0/6 0/6 !"#
Reovirus type 3 0/6 0/6 !"#
Sendai virus 0/6 0/6 !"#
Theiler's murine encephalomyelitis virus (TMEV) 0/6 0/6 !"#
Mycoplasma Mycoplasma pulmonis 0/6 0/6 !"#
Bacteria Chlostridium piliforme 0/6 0/3 $%!&#*+*!"#
Helicobacter Sp 0/6 0/6 '()
Parasites Endoparasites/Protozoan
2/6 (Chilomastix 
sp),  2/6 
(Hexamastix)
6/6 (Trichomonas sp),       
2/6 (Hexamastix sp)
n=6 mice per genotype IFA: Indirect Fluorescence Analaysis
PCR: Polymerase Chain Reaction
ELISA: Enzyme Linked Immuno Sorbent Assay
Table S2:Related to Figure 2. Blood biochemistry of Coronin 1-deficient mice (young and aged).
Table 1a
Parameter WT Stdev WT Cor1-/- Stdev KO WT Stdev WT Cor1-/- Stdev KO
Sodium (mmol/l) 151.67 1.53 154.00 1.00 156.64 2.06 154.45 1.21
Potassium (mmol/l) 10.17 0.67 9.93 1.91 5.41 0.46 5.93 0.61
Chloride (mmol/l) 112.33 0.58 116.67 3.79 105.27 1.35 106.09 1.97
Calcium (mmol/l) 2.66 0.09 2.60 0.10 1.97 0.78 2.33 0.07
Glucose (mmol/l) 8.23 5.08 11.66 3.90 5.06 1.44 6.85 1.19
Total Cholesterol (mmol/l) 2.10 0.49 1.95 0.27 2.31 0.79 2.68 0.26
HDL-Cholesterol (mmol/l) 1.42 0.26 1.28 0.39 2.36 0.20 2.52 0.22
Triglycerides (mmol/l) 1.20 0.23 1.36 0.43 1.34 0.38 0.98 0.23
Table 1b
Parameter  WT Stdev WT Cor1-/- Stdev KO
Magnesium (mmol/l) 1.43 0.15 1.51 0.23
Phosphate (mmol/l) 2.77 0.14 2.66 0.38
Urea (mmol/l) 7.07 0.57 9.00 1.85
Uric Acid (µmol/l) 213.00 8.49 256.33 63.85
Creatinine (mmol/l) 8.67 0.58 11.33 4.16
Chol./HDL-Chol-Quotient 1.47 0.15 1.58 0.28
Total Protein (g/l) 55.50 0.71 51.67 10.26
Albumin (g/l) 14.13 3.36 14.54 1.71
Globulin (g/l) 39.50 2.12 32.50 2.12
ASAT (U/l) 243.00 107.76 187.00 101.39
ALAT (U/l) 52.00 16.09 93.67 86.60
GGT (U/l) ND <1
Alk. Phosphatase (U/l) 78.00 73.82 104.67 68.31
Bilirubin (µmol/l) 1.90 0.17 2.24 0.71
n= 11 mice per genotype for young mice (<10 weeks)
n= 6 mice per genotype for aged mice (>30 weeks)
!"#$%&'()*&+%*,&'()*&
+%*,&'()*&
